Dynamics of Modified Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis on the Background of 5-Year Therapy with an Interleukin 6 Receptor Inhibitor.

Journal: Doklady. Biochemistry and biophysics
Published Date: May 11, 2025

Abstract

UNLABELLED: The effect of an inhibitor of interleukin (IL) 6 receptors on the state of the cardiovascular system in patients with rheumatoid arthritis (RA) remains poorly understood, especially with its long-term use.

Authors

  • E V Gerasimova
    Nasonova Research Institute of Rheumatology, Moscow, Russia. gerasimovaev@list.ru.
  • T V Popkova
    Nasonova Research Institute of Rheumatology, Moscow, Russia.
  • I G Kirillova
    Nasonova Research Institute of Rheumatology, Moscow, Russia.
  • D A Gerasimova
    Sechenov First Moscow State Medical University of the Ministry of Health Care of the Russian Federation (Sechenov University), Moscow, Russia.
  • E L Nasonov
    Nasonova Research Institute of Rheumatology, Moscow, Russia.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals